Next Financial Group’s Achillion Pharmaceuticals ACHN Stock Holding History

Next Financial Group’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-600	Closed	-$4K	–	2529
2019 Q4	$4K	Hold	600	–	–	﹤0.01%	2054
2019 Q3	$2K	Hold	600	–	–	﹤0.01%	2178
2019 Q2	$2K	Hold	600	–	–	﹤0.01%	2176
2019 Q1	$2K	Hold	600	–	–	﹤0.01%	1518
2018 Q4	$1K	Hold	600	–	–	﹤0.01%	1924
2018 Q3	$2K	Buy	+600	New	+$1.79K	﹤0.01%	1352
2017 Q4	–	Sell	-600	Closed	-$3K	–	1623
2017 Q3	$3K	Buy	+600	New	+$2.66K	﹤0.01%	1570
2016 Q4	–	Sell	-200	Closed	-$2K	–	2526
2016 Q3	$2K	Hold	200	–	–	﹤0.01%	2208
2016 Q2	$1K	Hold	200	–	–	﹤0.01%	1710
2016 Q1	$1K	Hold	200	–	–	﹤0.01%	1689
2015 Q4	$2K	Hold	200	–	–	﹤0.01%	1639
2015 Q3	$1K	Hold	200	–	–	﹤0.01%	1777
2015 Q2	$1K	Hold	200	–	–	﹤0.01%	1809
2015 Q1	$1K	Hold	200	–	–	﹤0.01%	1816
2014 Q4	$2K	Sell	200 -3,700	-95%	-$45.2K	﹤0.01%	1761
2014 Q3	$39K	Buy	+3,900	New	+$36.2K	0.01%	1074

Next Financial Group's ACHN Position: Q1 2020 in Review

Next Financial Group sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 600 shares — an estimated $4K sold.

Next Financial Group first reported a position in ACHN in Q3 2014 and held it in 16 quarters. The position peaked at $39K in Q3 2014. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Next Financial Group reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Next Financial Group sold 600 Achillion Pharmaceuticals shares in Q1 2020, an estimated $4K.
Next Financial Group first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 16 quarters.
Next Financial Group's Achillion Pharmaceuticals position peaked at $39K in Q3 2014.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Next Financial Group's 13F filing for Q1 2020, filed 27 Apr 2020.